Glucose Intolerance

"Glucose Intolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.

Descriptor ID	D018149
MeSH Number(s)	C18.452.394.952.500
Concept/Terms	Glucose Intolerance Glucose Intolerance Glucose Intolerances Intolerance, Glucose Intolerances, Glucose Impaired Glucose Tolerance Glucose Tolerance, Impaired Glucose Tolerances, Impaired Impaired Glucose Tolerances Tolerance, Impaired Glucose Tolerances, Impaired Glucose

Below are MeSH descriptors whose meaning is more general than "Glucose Intolerance".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Glucose Metabolism Disorders [C18.452.394]
Hyperglycemia [C18.452.394.952]
Glucose Intolerance [C18.452.394.952.500]

Below are MeSH descriptors whose meaning is related to "Glucose Intolerance".

Below are MeSH descriptors whose meaning is more specific than "Glucose Intolerance".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glucose Intolerance" by people in this website by year, and whether "Glucose Intolerance" was a major or minor topic of these publications.

Bar chart showing 57 publications over 21 distinct years, with a maximum of 7 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2002	1	0	1
2003	1	1	2
2004	1	0	1
2006	2	1	3
2007	0	1	1
2008	1	1	2
2009	1	1	2
2010	2	0	2
2011	0	3	3
2012	2	2	4
2013	7	0	7
2014	2	2	4
2015	4	1	5
2016	3	3	6
2017	2	1	3
2018	0	1	1
2020	2	0	2
2021	2	3	5
2022	1	0	1
2024	0	1	1

Below are the most recent publications written about "Glucose Intolerance" by people in Profiles.

Jollet M, Tramontana F, Jiang LQ, Borg ML, Savikj M, Kuefner MS, Massart J, de Castro Barbosa T, Manner?s-Holm L, Checa A, Pillon NJ, Chibalin AV, Bj?rnholm M, Zierath JR. Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity. Metabolism. 2024 Sep; 158:155939.

View in: PubMed
Wilkie G, Leung K, Moore Simas TA, Tucker KL, Chasan-Taber L. The Association Between Acculturation and Diet and Physical Activity Among Pregnant Hispanic Women with Abnormal Glucose Tolerance. J Womens Health (Larchmt). 2022 12; 31(12):1791-1799.

View in: PubMed
Bengtson AM, Dice ALE, Clark MA, Gutman R, Rouse D, Werner E. Predicting Progression from Gestational Diabetes to Impaired Glucose Tolerance Using Peridelivery Data: An Observational Study. Am J Perinatol. 2024 05; 41(S 01):e282-e289.

View in: PubMed
Tsagkaraki E, Nicoloro SM, DeSouza T, Solivan-Rivera J, Desai A, Lifshitz LM, Shen Y, Kelly M, Guilherme A, Henriques F, Amrani N, Ibraheim R, Rodriguez TC, Luk K, Maitland S, Friedline RH, Tauer L, Hu X, Kim JK, Wolfe SA, Sontheimer EJ, Corvera S, Czech MP. CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease. Nat Commun. 2021 Nov 26; 12(1):6931.

View in: PubMed
Wilkie G, Delpapa E, Leftwich H. Early Diagnosis of Prediabetes among Pregnant Women that Develop Gestational Diabetes Mellitus and Its Influence on Perinatal Outcomes. Am J Perinatol. 2024 02; 41(3):343-348.

View in: PubMed
Mills EL, Harmon C, Jedrychowski MP, Xiao H, Garrity R, Tran NV, Bradshaw GA, Fu A, Szpyt J, Reddy A, Prendeville H, Danial NN, Gygi SP, Lynch L, Chouchani ET. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat Metab. 2021 05; 3(5):604-617.

View in: PubMed
Darukhanavala A, Van Dessel F, Ho J, Hansen M, Kremer T, Alfego D. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis. PLoS One. 2021; 16(4):e0250036.

View in: PubMed
Fujimoto BA, Young M, Nakamura N, Ha H, Carter L, Pitts MW, Torres D, Noh HL, Suk S, Kim JK, Polgar N. Disrupted glucose homeostasis and skeletal-muscle-specific glucose uptake in an exocyst knockout mouse model. J Biol Chem. 2021 Jan-Jun; 296:100482.

View in: PubMed
Wang G, Yu Y, Cai W, Batista TM, Suk S, Noh HL, Hirshman M, Nigro P, Li ME, Softic S, Goodyear L, Kim JK, Kahn CR. Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance. Diabetes. 2020 11; 69(11):2294-2309.

View in: PubMed
van der Vinne V, Martin Burgos B, Harrington ME, Weaver DR. Deconstructing circadian disruption: Assessing the contribution of reduced peripheral oscillator amplitude on obesity and glucose intolerance in mice. J Pineal Res. 2020 Aug; 69(1):e12654.

View in: PubMed

People

Explore

Similar Concepts

Top Journals